A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening

Noemi Vidal-Folch, Dragana Milosevic, Ramanath Majumdar, Dimitar Gavrilov, Dietrich Matern, Kimiyo Raymond, Piero Rinaldo, Silvia Tortorelli, Roshini S. Abraham, Devin Oglesbee

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Severe combined immunodeficiency (SCID) benefits from early intervention via hematopoietic cell transplantation to reverse T-cell lymphopenia (TCL). Newborn screening (NBS) programs use T-cell receptor excision circle (TREC) levels to detect SCID. Real-time quantitative PCR is often performed to quantify TRECs in dried blood spots (DBSs) for NBS. Yet, real-time quantitative PCR has inefficiencies necessitating normalization, repeat analyses, or standard curves. To address these issues, we developed a multiplex, droplet digital PCR (ddPCR) method for measuring absolute TREC amounts in one DBS punch. TREC and RPP30 levels were simultaneously measured with a Bio-Rad AutoDG and QX200 ddPCR system. DBSs from 610 presumed-normal, 29 lymphocyte-profiled, and 10 clinically diagnosed infants (1 X-linked SCID, 1 RAG1 Omenn syndrome, and other conditions) were tested. Control infants showed 14 to 474 TREC copies/μL blood. SCID infants, and other TCL conditions, had ≤15 TREC copies/μL. The ddPCR lower limit of quantitation was 14 TREC copies/μL, and the limit of detection was 4 TREC copies/μL. Intra-assay and interassay imprecision was <20% CV for DBSs at 54 to 60 TREC copies/μL. Testing 29 infants with known lymphocyte profiles resulted in a sensitivity of 88.9% and a specificity of 100% at TRECs <20 copies/μL. We developed a multiplex ddPCR method for the absolute quantitation of DBS TRECs that can detect SCID and other TCL conditions associated with absent or low TRECs and validated this method for NBS.

Original languageEnglish (US)
Pages (from-to)755-765
Number of pages11
JournalJournal of Molecular Diagnostics
Volume19
Issue number5
DOIs
StatePublished - Sep 1 2017

Fingerprint

Severe Combined Immunodeficiency
T-Cell Antigen Receptor
Newborn Infant
Polymerase Chain Reaction
Lymphopenia
T-Lymphocytes
Real-Time Polymerase Chain Reaction
X-Linked Combined Immunodeficiency Diseases
Lymphocytes
Cell Transplantation
Limit of Detection

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine

Cite this

A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening. / Vidal-Folch, Noemi; Milosevic, Dragana; Majumdar, Ramanath; Gavrilov, Dimitar; Matern, Dietrich; Raymond, Kimiyo; Rinaldo, Piero; Tortorelli, Silvia; Abraham, Roshini S.; Oglesbee, Devin.

In: Journal of Molecular Diagnostics, Vol. 19, No. 5, 01.09.2017, p. 755-765.

Research output: Contribution to journalArticle

Vidal-Folch, N, Milosevic, D, Majumdar, R, Gavrilov, D, Matern, D, Raymond, K, Rinaldo, P, Tortorelli, S, Abraham, RS & Oglesbee, D 2017, 'A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening', Journal of Molecular Diagnostics, vol. 19, no. 5, pp. 755-765. https://doi.org/10.1016/j.jmoldx.2017.05.011
Vidal-Folch N, Milosevic D, Majumdar R, Gavrilov D, Matern D, Raymond K et al. A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening. Journal of Molecular Diagnostics. 2017 Sep 1;19(5):755-765. https://doi.org/10.1016/j.jmoldx.2017.05.011
Vidal-Folch, Noemi ; Milosevic, Dragana ; Majumdar, Ramanath ; Gavrilov, Dimitar ; Matern, Dietrich ; Raymond, Kimiyo ; Rinaldo, Piero ; Tortorelli, Silvia ; Abraham, Roshini S. ; Oglesbee, Devin. / A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening. In: Journal of Molecular Diagnostics. 2017 ; Vol. 19, No. 5. pp. 755-765.
@article{d7b19c6bf12548a0b5e8c04f252eb5a8,
title = "A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening",
abstract = "Severe combined immunodeficiency (SCID) benefits from early intervention via hematopoietic cell transplantation to reverse T-cell lymphopenia (TCL). Newborn screening (NBS) programs use T-cell receptor excision circle (TREC) levels to detect SCID. Real-time quantitative PCR is often performed to quantify TRECs in dried blood spots (DBSs) for NBS. Yet, real-time quantitative PCR has inefficiencies necessitating normalization, repeat analyses, or standard curves. To address these issues, we developed a multiplex, droplet digital PCR (ddPCR) method for measuring absolute TREC amounts in one DBS punch. TREC and RPP30 levels were simultaneously measured with a Bio-Rad AutoDG and QX200 ddPCR system. DBSs from 610 presumed-normal, 29 lymphocyte-profiled, and 10 clinically diagnosed infants (1 X-linked SCID, 1 RAG1 Omenn syndrome, and other conditions) were tested. Control infants showed 14 to 474 TREC copies/μL blood. SCID infants, and other TCL conditions, had ≤15 TREC copies/μL. The ddPCR lower limit of quantitation was 14 TREC copies/μL, and the limit of detection was 4 TREC copies/μL. Intra-assay and interassay imprecision was <20{\%} CV for DBSs at 54 to 60 TREC copies/μL. Testing 29 infants with known lymphocyte profiles resulted in a sensitivity of 88.9{\%} and a specificity of 100{\%} at TRECs <20 copies/μL. We developed a multiplex ddPCR method for the absolute quantitation of DBS TRECs that can detect SCID and other TCL conditions associated with absent or low TRECs and validated this method for NBS.",
author = "Noemi Vidal-Folch and Dragana Milosevic and Ramanath Majumdar and Dimitar Gavrilov and Dietrich Matern and Kimiyo Raymond and Piero Rinaldo and Silvia Tortorelli and Abraham, {Roshini S.} and Devin Oglesbee",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.jmoldx.2017.05.011",
language = "English (US)",
volume = "19",
pages = "755--765",
journal = "Journal of Molecular Diagnostics",
issn = "1525-1578",
publisher = "Association of Molecular Pathology",
number = "5",

}

TY - JOUR

T1 - A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening

AU - Vidal-Folch, Noemi

AU - Milosevic, Dragana

AU - Majumdar, Ramanath

AU - Gavrilov, Dimitar

AU - Matern, Dietrich

AU - Raymond, Kimiyo

AU - Rinaldo, Piero

AU - Tortorelli, Silvia

AU - Abraham, Roshini S.

AU - Oglesbee, Devin

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Severe combined immunodeficiency (SCID) benefits from early intervention via hematopoietic cell transplantation to reverse T-cell lymphopenia (TCL). Newborn screening (NBS) programs use T-cell receptor excision circle (TREC) levels to detect SCID. Real-time quantitative PCR is often performed to quantify TRECs in dried blood spots (DBSs) for NBS. Yet, real-time quantitative PCR has inefficiencies necessitating normalization, repeat analyses, or standard curves. To address these issues, we developed a multiplex, droplet digital PCR (ddPCR) method for measuring absolute TREC amounts in one DBS punch. TREC and RPP30 levels were simultaneously measured with a Bio-Rad AutoDG and QX200 ddPCR system. DBSs from 610 presumed-normal, 29 lymphocyte-profiled, and 10 clinically diagnosed infants (1 X-linked SCID, 1 RAG1 Omenn syndrome, and other conditions) were tested. Control infants showed 14 to 474 TREC copies/μL blood. SCID infants, and other TCL conditions, had ≤15 TREC copies/μL. The ddPCR lower limit of quantitation was 14 TREC copies/μL, and the limit of detection was 4 TREC copies/μL. Intra-assay and interassay imprecision was <20% CV for DBSs at 54 to 60 TREC copies/μL. Testing 29 infants with known lymphocyte profiles resulted in a sensitivity of 88.9% and a specificity of 100% at TRECs <20 copies/μL. We developed a multiplex ddPCR method for the absolute quantitation of DBS TRECs that can detect SCID and other TCL conditions associated with absent or low TRECs and validated this method for NBS.

AB - Severe combined immunodeficiency (SCID) benefits from early intervention via hematopoietic cell transplantation to reverse T-cell lymphopenia (TCL). Newborn screening (NBS) programs use T-cell receptor excision circle (TREC) levels to detect SCID. Real-time quantitative PCR is often performed to quantify TRECs in dried blood spots (DBSs) for NBS. Yet, real-time quantitative PCR has inefficiencies necessitating normalization, repeat analyses, or standard curves. To address these issues, we developed a multiplex, droplet digital PCR (ddPCR) method for measuring absolute TREC amounts in one DBS punch. TREC and RPP30 levels were simultaneously measured with a Bio-Rad AutoDG and QX200 ddPCR system. DBSs from 610 presumed-normal, 29 lymphocyte-profiled, and 10 clinically diagnosed infants (1 X-linked SCID, 1 RAG1 Omenn syndrome, and other conditions) were tested. Control infants showed 14 to 474 TREC copies/μL blood. SCID infants, and other TCL conditions, had ≤15 TREC copies/μL. The ddPCR lower limit of quantitation was 14 TREC copies/μL, and the limit of detection was 4 TREC copies/μL. Intra-assay and interassay imprecision was <20% CV for DBSs at 54 to 60 TREC copies/μL. Testing 29 infants with known lymphocyte profiles resulted in a sensitivity of 88.9% and a specificity of 100% at TRECs <20 copies/μL. We developed a multiplex ddPCR method for the absolute quantitation of DBS TRECs that can detect SCID and other TCL conditions associated with absent or low TRECs and validated this method for NBS.

UR - http://www.scopus.com/inward/record.url?scp=85027680296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027680296&partnerID=8YFLogxK

U2 - 10.1016/j.jmoldx.2017.05.011

DO - 10.1016/j.jmoldx.2017.05.011

M3 - Article

C2 - 28826609

AN - SCOPUS:85027680296

VL - 19

SP - 755

EP - 765

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 5

ER -